Home > Insider Trading > Filing (0001140361-15-034401)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437402	Ardelyx Inc.	ARDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611311	P. David Rosenbaum	C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 100 Fremont CA 94555	Svp, Drug Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-01	1,286	$18.32	0	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2015-09-03	1,251	$19.25	25,880	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	77,592	Indirect	See Footnote

Footnotes

Consists of 1,286 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.
The shares are directly held by the reporting person's wife.
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 18, 2015.
Consists of 1,251 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.
The reporting person no longer has a reportable beneficial interest in 2,777 shares of the Issuer's common stock owned by his son and 2,777 shares of the Issuer's common stock owned by each of his two daughters, which shares were included in the reporting person's prior ownership reports.
The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.